Next-Generation Blood Pumps

A revolutionary, miniaturized, and implantable blood pump system that wirelessly harnesses external energy and adapts to individual circulatory needs, enabling personalized, long-term circulatory support.

The original patent disclosed blood pumps with limitations in size, power supply, and adaptability to individual patients. The next-generation blood pumps address these limitations by introducing miniaturized, implantable, and wirelessly powered pump modules that adapt to a patient's anatomy and circulatory needs.

The inventive concept comprises a miniaturized, implantable pump module that is powered wirelessly through inductive coupling with an external energy source. This enables long-term implantation within a patient's circulatory system. The pump module features a self-sustaining, bio-inspired propulsion mechanism that mimics the natural pumping action of the heart, minimizing energy consumption and maximizing circulatory support. Additionally, the system incorporates a closed-loop control mechanism that utilizes real-time, AI-driven monitoring of a patient's hemodynamic parameters to optimize pump performance and ensure personalized, adaptive circulatory support.

The inventive concept's novelty lies in its miniaturized, implantable, and wirelessly powered design, which enables long-term implantation and personalized circulatory support. The inventive step is the integration of bio-inspired propulsion mechanisms and AI-driven control systems, which revolutionize the field of blood pumps.

Alternative embodiments of the inventive concept include swarm-based micro-pumps, wearable, non-invasive blood pump devices, and flexible, conformable pump elements driven by artificial muscle technology. These variations ensure broad conceptual coverage and adaptability to diverse patient needs.

The next-generation blood pumps have vast commercial potential in the medical device industry, targeting applications in cardiac assist devices, mechanical circulatory support, and personalized medicine. The market for these devices is expected to grow significantly, driven by the increasing demand for minimally invasive, long-term circulatory support solutions.